The role of the gut microbiome and its metabolites in altering the therapeutic outcomes
Lasers, cardiology, clinical trials: 2023’s top private equity targets
By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies. Even